151 related articles for article (PubMed ID: 33957019)
1. The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery.
Jeong H; Park KJ; Lee Y; Kim HD; Kim JH; Yoon S; Hong B; Lee JL
Cancer Res Treat; 2022 Jan; 54(1):226-233. PubMed ID: 33957019
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer.
Kanatani A; Nakagawa T; Kawai T; Naito A; Sato Y; Yoshida K; Nozaki K; Nagata M; Yamada Y; Azuma T; Suzuki M; Fujimura T; Fukuhara H; Nishimatsu H; Kume H; Igawa Y; Homma Y
Clin Genitourin Cancer; 2015 Apr; 13(2):e107-12. PubMed ID: 25456839
[TBL] [Abstract][Full Text] [Related]
3. Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
Guzzo TJ; Resnick MJ; Canter DJ; Balandra A; Bergey MR; Magerfleisch L; Tomaszewski JE; Vaughn DJ; Malkowicz SB
Can J Urol; 2010 Dec; 17(6):5465-71. PubMed ID: 21172112
[TBL] [Abstract][Full Text] [Related]
4. Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
Hinata N; Hussein AA; George S; Trump DL; Levine EG; Omar K; Dasgupta P; Khan MS; Hosseini A; Wiklund P; Guru KA
BJU Int; 2017 Apr; 119(4):605-611. PubMed ID: 27743481
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03.
Bae WK; Lee HJ; Park SH; Kim JH; Kim HJ; Maeng CH; Park I; Sohn BS; Kim JA; Lee KH; Lim DH; Chang H; Kim SM; Kim HY; Song H; Lim S; Byun JH; Jung HA
Cancer Med; 2019 Sep; 8(12):5431-5437. PubMed ID: 31353788
[TBL] [Abstract][Full Text] [Related]
8. Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone.
Mertens LS; Meijer RP; Meinhardt W; van der Poel HG; Bex A; Kerst JM; van der Heijden MS; Bergman AM; Horenblas S; van Rhijn BW
BJU Int; 2014 Jul; 114(1):67-74. PubMed ID: 24053889
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
Stein JP; Cai J; Groshen S; Skinner DG
J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
[TBL] [Abstract][Full Text] [Related]
10. The role of adjuvant chemotherapy in patients with locally advanced (pT3, pT4a) and/or lymph node-positive bladder cancer.
Reşorlu B; Türkölmez K; Ergün G; Baltacı S; Göğüş C; Bedük Y
Int Urol Nephrol; 2010 Dec; 42(4):959-64. PubMed ID: 20405206
[TBL] [Abstract][Full Text] [Related]
11. Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy.
Cha EK; Sfakianos JP; Sukhu R; Yee AM; Sjoberg DD; Bochner BH
BJU Int; 2018 Oct; 122(4):627-632. PubMed ID: 29633530
[TBL] [Abstract][Full Text] [Related]
12. [The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer].
Habuchi T; Kakehi Y; Terachi T; Ogawa O; Yoshida O
Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):809-17. PubMed ID: 10565159
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
Zehnder P; Studer UE; Daneshmand S; Birkhäuser FD; Skinner EC; Roth B; Miranda G; Burkhard FC; Cai J; Skinner DG; Thalmann GN; Gill IS
BJU Int; 2014 Apr; 113(4):554-60. PubMed ID: 24131453
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder.
Fleischmann A; Thalmann GN; Markwalder R; Studer UE
Am J Surg Pathol; 2005 Jan; 29(1):89-95. PubMed ID: 15613859
[TBL] [Abstract][Full Text] [Related]
15. [Neoadjuvant, inductive or adjuvant chemotherapy of bladder cancer].
Ohlmann CH; De Santis M
Urologe A; 2013 Nov; 52(11):1534-8, 1540. PubMed ID: 24197083
[TBL] [Abstract][Full Text] [Related]
16. [Oncological results of a series of 93 laparoscopic radical cystectomies: 5 years of follow-up].
Moudouni SM; Latabi AF; Aarab M; Lakmichi MA; Dahami Z; Sarf I
Prog Urol; 2019 Feb; 29(2):86-94. PubMed ID: 30584022
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Lymph Node Density in Pathological Node Positive Urothelial Carcinoma of the Bladder -Upfront Surgery and Post Neoadjuvant Chemotherapy Cohorts.
Jaganmurugan R; Arora A; Chandankhede U; Prakash G; Bakshi G; Joshi A; Menon S; Murthy V; Pal M
Clin Genitourin Cancer; 2024 Apr; 22(2):385-393. PubMed ID: 38245435
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classification.
Sakura Y; Yamashita R; Notsu A; Usui K; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M
Int J Urol; 2024 Apr; ():. PubMed ID: 38606834
[TBL] [Abstract][Full Text] [Related]
19. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.
Bandini M; Briganti A; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Sridhar SS; Sternberg CN; Vaishampayan U; Théodore C; Rosenberg JE; Bellmunt J; Galsky MD; Montorsi F; Necchi A
Eur Urol Oncol; 2019 May; 2(3):248-256. PubMed ID: 31200838
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting.
Kwon T; Jeong IG; Lee J; Lee C; You D; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2015 Jan; 141(1):169-76. PubMed ID: 25119986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
